Amedalin

Amedalin (UK-3540-1) is an antidepressant which was synthesized in the early 1970s but was never marketed.^[1][2] It is a selective norepinephrine reuptake inhibitor, with no significant effects on the reuptake of serotonin and dopamine, and no antihistamine or anticholinergic properties.^[2][3]

Amedalin

Clinical data
ATC code	None
Identifiers
IUPAC name 3-Methyl-3-[3-(methylamino)propyl]-1-phenyl-1,3-dihydro-2H-indol-2-one
CAS Number	22136-26-1 Y 22232-73-1 (HCl)
PubChem CID	31075
ChemSpider	28832 Y
UNII	2OWK6X9N16
KEGG	D02891 N
ChEMBL	ChEMBL2110769 N
CompTox Dashboard (EPA)	DTXSID40865034
Chemical and physical data
Formula	C19H22N2O
Molar mass	294.398 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1(C2=CC=CC=C2N(C1=O)C3=CC=CC=C3)CCCNC
InChI InChI=1S/C19H22N2O/c1-19(13-8-14-20-2)16-11-6-7-12-17(16)21(18(19)22)15-9-4-3-5-10-15/h3-7,9-12,20H,8,13-14H2,1-2H3 Y Key:HBGWAZBZXJBYQD-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

See also

• Daledalin